Skip to content

Pietro Benedito

Centre de Recherche Médecine, Sciences, Santé, Santé Mentale, Société

2 papers in the library · 2 citations · publishing 2024-2025

Papers

Psychedelic Nation? (De)Provincializing the Psychedelic Renaissance from Brazil

Science Technology & Human Values December 20, 2024 Pietro Benedito, Emilia Sanabria 2 citations

Brazil has developed a distinctive, globally relevant research paradigm for psychedelic substances, driven by a strong pharmaceutical innovation system and the legal status of ayahuasca. Unlike most countries, this research is primarily publicly funded through universities, showcasing Latin America's ability to produce competitive science despite severe financial limitations. Shaped by traditions of social medicine, psychiatric reform, and harm reduction activism, Brazilian psychedelic science maintains close ties to local communities, particularly ayahuasca churches that partner with clinical research labs. The authors argue that provincializing the psychedelic renaissance means challenging the patent-driven, neoliberal mindset that makes a shared, publicly funded psychedelic research commons seem impossible, an ideal quietly put into practice in Brazil as long as its universities received adequate public funding.

Future Ayahuasca Care Spaces: An Experimental Speculative Exercise

Vibrant Virtual Brazilian Anthropology January 1, 2025 Pietro Benedito, Isabel Santana de Rose, Emilia Sanabria et al.

As psychedelic-assisted therapy (PAT) trials advance, clinics offering such treatments are becoming a near-term reality, raising questions about therapeutic modalities, infrastructure, funding, and access. This paper describes the process of designing and holding a speculative space to imagine possible future ayahuasca care spaces. Ayahuasca healing remains largely tied to ritual settings, creating a complex and ambivalent relationship with the broader category of psychedelics and PATs. Through speculation, the authors collaboratively addressed issues of appropriation, commodification, standardization, and pharmaceuticalization of plant medicines, while exploring the more-than-human dimensions of care. The goal was to shift interactions with field interlocutors toward co-laboration and co-re-definition, discussing the creation, parameters, and framework of such a conversation.